Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Klotho Neurosciences, Inc. (KLTO : NSDQ)

• Company Description    Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc., formerly known as ANEW MEDICAL INC., is based in NEW YORK. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $1.46 Daily Weekly Monthly 20 Day Moving Average: 15,713,035 shares Shares Outstanding: 52.70 (millions) Market Capitalization: $76.95 (millions) Beta: 11.08 52 Week High: $2.45 52 Week Low: $0.11 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -27.00% -29.73% 12 Week 758.82% 622.39% Year To Date 201.03% 181.91%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 13576 WALNUT STREET SUITE A - OMAHA,NE 68144 USA ph: 833-931-6330 fax: - None http://www.klothoneuro.com

• General Corporate Information    Officers Joseph A. Sinkule - Chief Executive Officer Jeffrey LeBlanc - Chief Financial Officer Samuel Zentman - Director Riad El-Dada - Director Jon McGarity - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 49876K103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/18/25 Share - Related Items Shares Outstanding: 52.70 Most Recent Split Date: (:1) Beta: 11.08 Market Capitalization: $76.95 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/18/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 64.00 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -14.29% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -1,779.01 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -275.01 12/31/24 - -88.44 Current Ratio 06/30/25 - - 03/31/25 - 0.29 12/31/24 - 0.13 Quick Ratio 06/30/25 - - 03/31/25 - 0.29 12/31/24 - 0.13 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 0.02 12/31/24 - 0.04 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©